| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.49 | 6e-22 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-14 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0008 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |